Envision Pharma Group’s Post

This article by Jessica Krauser, Jasmine Patel, and Amanda Boughey highlights the crucial role of patient advocacy in the life sciences. At Envision Pharma Group, patients' voices guide every step of the healthcare journey—from research and development to communication and engagement. Patient advocacy is a cornerstone of how we shape the future of healthcare. By listening to and amplifying patient perspectives, we drive change, ensuring medical innovations meet the needs of those they are designed to help. The article explores how we’re integrating patient voices into our strategies, making advocacy a catalyst for action.

The pharmaceutical industry is embracing a revolutionary shift: patient centricity. Gone are the days of top-down decision-making. Today, patient insights drive both commercial and clinical strategies. Disease foundations, advocacy groups, regulators, physicians, and tech innovators are joining forces to place patients and caregivers at the heart of our ecosystem. This patient-first approach is not just a trend but a strategic imperative, ensuring every solution is tailored to real-world needs. By mapping patient journeys and integrating their voices, we’re achieving better health outcomes and enhancing the patient experience. The future of pharma is here, and it's all about empowering the patient. #PatientCentricity

How can pharma enhance patient engagement? Simple. Create and nurture online communities. Personalized medicine is transforming healthcare by tailoring treatments to individual needs. Smart Patients offers a unique platform for pharmaceutical companies to engage with patients through online communities, providing peer support and valuable insights. - Build Communities: Partner with Smart Patients to create supportive online spaces where patient experiences are prioritized. - Leverage Insights: Use real-world patient feedback to inform drug development and improve healthcare solutions. - Promote Patient-Centered Care: Focus on patient goals and support caregivers to enhance overall care. - Foster Collaboration: Create a respectful environment for meaningful interactions and patient empowerment. Join the movement from passive care to active collaboration. Partner with Smart Patients to enhance engagement, support personalized medicine, and drive innovation. Learn more here: https://ow.ly/pJtq50StutL #PharmaEngagement #PersonalizedMedicine #SmartPatients #HealthcareSolutions

Achieving market access in the healthcare sector can feel like solving a complex puzzle. With so many variables at play, a strategic integrated evidence generation plan becomes essential. The article highlights the importance of adopting a data-driven approach, ensuring that all evidence aligns with market realities. Start by clearly defining your objectives and understanding the market landscape; this will guide your evidence generation. Engaging stakeholders early and often can shape your strategy effectively. Additionally, leveraging technology can streamline data collection and analysis, making it easier to present your findings convincingly. The payoff? A well-crafted plan not only accelerates market access but also builds trust with stakeholders, ultimately leading to better patient outcomes. What strategies have you found effective in navigating market access challenges? Share your insights below! https://lnkd.in/g3MnAQzS CapSys Group

Biopharma's Bold Move: Direct to Consumer Revolutionizing Healthcare Access Pfizer has launched PfizerForAll™, a groundbreaking digital platform aimed at simplifying healthcare access for millions of Americans. This innovative approach addresses key pain points in the U.S. healthcare system: - Same-day healthcare professional appointments - Home delivery of medicines and tests - Vaccine scheduling - Streamlined access to patient support services By integrating critical resources into a single user-friendly platform, Pfizer is tackling the overwhelming nature of healthcare management. This initiative reflects a growing trend of biopharma companies engaging directly with consumers, potentially reshaping the healthcare landscape. As the industry evolves, we're witnessing a shift towards patient-centric, technology-driven solutions. How might this impact traditional healthcare delivery models? Will Indian Pharma companies embrace this patient-centric, tech-driven model to enhance accessibility? What are your thoughts? #HealthcareInnovation #DigitalHealth #PatientAccess

➡️The Power of Early Patient Insights Historically, patient MR has been pushed to the later stages—usually near product launch or even after. It was mainly considered a tool for shaping marketing strategies, patient support programs, or adherence tools. Today, forward-thinking companies are recognizing the commercial and clinical benefits of integrating patient input from the earliest stages of development. So why do early patient insights matter? Phase 1️⃣ Early feedback from a broader group of target patients on preferences (e.g., oral vs. injectable) and disease burden can help align drug development with real needs and expectations. Phase 2️⃣ Insights into patient preferences can optimize trial design, enhance recruitment and retention and identify unmet needs beyond the trial population to ensure your product can address real-world needs. Phase 3️⃣ Pre-launch insights into how the treatment could perform in real-world scenarios can help in preparing marketing and communication strategies, developing additional support programs, and strengthening regulatory submissions. Still, many companies are slow to adopt this early approach. Why? Decisions may still be driven by the outcomes of early regulatory meetings, and there never seems to be enough time. Given that billions are spent on drug development, it’s hard to believe cost could be a concern. Or maybe it is just an old mindset still lingering. What else could hold this back? If you agree with the importance of early patient insight, give us a thumbs-up 👍 #Pharmamarketing #marketresearch #patientmarketresearch #DrugDevelopment #PatientCentricity #ClinicalTrials #HealthcareInnovation

"🚀 The future of clinical trials conduct optimization is here! At Clinergy Health, we're excited about how our Risk-Based Study Execution tools and processes can improve data quality while reducing clinical trials monitoring costs by 30-50%. How do you see technology shaping the future of healthcare? Let's discuss! #Clinergyhealth #HealthTech #Innovation #ClinergyHealth #Clinicaltrials #clinicaldevelopment #clinicalresearch #cro #pharmaceuticalindustry

Digital health will be critical for enabling pharma's commercial model of the future. Patient & HCP engagement through digital tools creates new routes to (high velocity) first-party data transforming our understanding of decision-making CONTEXT. What's more, digital health then provides us with the means to act on this data, by shifting the value creation model from 'selling medicines' to 'enabling outcomes'. This becomes a virtuous cycle. Learn more: https://bit.ly/4czhhIS #pharma #customerengagement #futureofcommercialmodel

Latest PharmaTimes Media Ltd issue is out for April. Spotted this interesting article on transforming #marketaccess through patient perspectives. It touches upon evidence generation in pre and post-launch phases - with a shift needed towards putting patient engagement into every aspect of a product's life cycle (music to the Vitaccess team's ears!). If you're short on time, here's the summary: "Implementing a patient-centric strategy effectively requires forging partnerships across various stakeholders. Moreover, meaningful patient engagement may require specific data-collection methods to ensure patient input is accurately captured and valued. In placing patients at the heart of market access strategies, companies can not only enhance drug development and commercialisation but could also contribute to a more equitable and responsive healthcare ecosystem. By listening to and learning from patients throughout the drug life cycle, companies can ensure that the therapies they bring to market are not only innovative, but also accessible and aligned with real-world data points on patient needs." Link to full article in comments. #realworldevidence #patientengagement

Exciting possibilities lie ahead as the AI revolution is set to reshape healthcare; making it predictive, preventive, and personalised. Connected care offers transformative benefits, forging new partnerships and reshaping the industry's dynamics. Yet the blueprint to orchestrate these technology building blocks for greater innovation in care, is still in progress. In a global survey conducted by us, 375 senior decision-makers across healthcare sub-sectors shared insights on the impact of connected care. The survey spanned across North America (40%), Europe (40%), and other geographies (20%), drawing participants from healthcare providers, payers, pharmacies, pharmaceutical manufacturers, and medtech providers. Our research report delves into the nuances of this exciting shift, painting a picture of a healthcare future where all stakeholders have a hand in its reinvention. The change is imminent, and we all have a role in reshaping healthcare for a better tomorrow. Find out more: https://lnkd.in/gEeUjAKR #Healthcare